Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 100% | 7777.72 | 966 / 966 | 99% | 38.33 | 523 / 527 |
prostate | 100% | 8283.60 | 245 / 245 | 99% | 46.78 | 498 / 502 |
stomach | 100% | 4707.85 | 359 / 359 | 98% | 32.15 | 281 / 286 |
liver | 100% | 3963.30 | 226 / 226 | 98% | 25.55 | 398 / 406 |
kidney | 100% | 7946.45 | 89 / 89 | 97% | 57.87 | 871 / 901 |
lung | 100% | 8617.46 | 578 / 578 | 95% | 27.00 | 1102 / 1155 |
bladder | 100% | 5067.19 | 21 / 21 | 95% | 32.40 | 480 / 504 |
thymus | 100% | 5388.98 | 653 / 653 | 94% | 30.79 | 571 / 605 |
breast | 100% | 6007.53 | 459 / 459 | 93% | 21.72 | 1040 / 1118 |
uterus | 100% | 5776.26 | 170 / 170 | 93% | 27.95 | 426 / 459 |
skin | 85% | 2808.53 | 1540 / 1809 | 100% | 111.75 | 470 / 472 |
esophagus | 100% | 3940.91 | 1444 / 1445 | 81% | 19.36 | 149 / 183 |
pancreas | 81% | 1406.30 | 266 / 328 | 97% | 45.40 | 173 / 178 |
ovary | 100% | 4216.36 | 180 / 180 | 78% | 13.39 | 336 / 430 |
adrenal gland | 100% | 6885.22 | 258 / 258 | 77% | 18.39 | 178 / 230 |
adipose | 100% | 5356.07 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 179.36 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 85.92 | 29 / 29 |
spleen | 100% | 14193.86 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 8.27 | 1 / 1 |
peripheral blood | 99% | 8078.29 | 920 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 94% | 2543.11 | 1257 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 28.45 | 42 / 45 |
brain | 42% | 582.46 | 1104 / 2642 | 44% | 7.01 | 313 / 705 |
heart | 85% | 1666.33 | 728 / 861 | 0% | 0 | 0 / 0 |
muscle | 15% | 195.49 | 124 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0046642 | Biological process | negative regulation of alpha-beta T cell proliferation |
GO_0045087 | Biological process | innate immune response |
GO_0002720 | Biological process | positive regulation of cytokine production involved in immune response |
GO_0050829 | Biological process | defense response to Gram-negative bacterium |
GO_0031295 | Biological process | T cell costimulation |
GO_0006955 | Biological process | immune response |
GO_0002250 | Biological process | adaptive immune response |
GO_0046718 | Biological process | symbiont entry into host cell |
GO_0050830 | Biological process | defense response to Gram-positive bacterium |
GO_0050731 | Biological process | positive regulation of peptidyl-tyrosine phosphorylation |
GO_1905675 | Biological process | negative regulation of adaptive immune memory response |
GO_2000406 | Biological process | positive regulation of T cell migration |
GO_0033209 | Biological process | tumor necrosis factor-mediated signaling pathway |
GO_0007166 | Biological process | cell surface receptor signaling pathway |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0019955 | Molecular function | cytokine binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0001618 | Molecular function | virus receptor activity |
GO_0005031 | Molecular function | tumor necrosis factor receptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | TNFRSF14 |
Protein name | Tumor necrosis factor receptor superfamily member 14 (Herpes virus entry mediator A) (Herpesvirus entry mediator A) (HveA) (Tumor necrosis factor receptor-like 2) (TR2) (CD antigen CD270) TNF receptor superfamily member 14 (Tumor necrosis factor receptor superfamily member 14) |
Synonyms | HVEA HVEM UNQ329/PRO509 |
Description | FUNCTION: Receptor for four distinct ligands: The TNF superfamily members TNFSF14/LIGHT and homotrimeric LTA/lymphotoxin-alpha and the immunoglobulin superfamily members BTLA and CD160, altogether defining a complex stimulatory and inhibitory signaling network . Signals via the TRAF2-TRAF3 E3 ligase pathway to promote immune cell survival and differentiation . Participates in bidirectional cell-cell contact signaling between antigen presenting cells and lymphocytes. In response to ligation of TNFSF14/LIGHT, delivers costimulatory signals to T cells, promoting cell proliferation and effector functions . Interacts with CD160 on NK cells, enhancing IFNG production and anti-tumor immune response . In the context of bacterial infection, acts as a signaling receptor on epithelial cells for CD160 from intraepithelial lymphocytes, triggering the production of antimicrobial proteins and pro-inflammatory cytokines (By similarity). Upon binding to CD160 on activated CD4+ T cells, down-regulates CD28 costimulatory signaling, restricting memory and alloantigen-specific immune response . May interact in cis (on the same cell) or in trans (on other cells) with BTLA (By similarity). In cis interactions, appears to play an immune regulatory role inhibiting in trans interactions in naive T cells to maintain a resting state. In trans interactions, can predominate during adaptive immune response to provide survival signals to effector T cells (By similarity). .; FUNCTION: (Microbial infection) Acts as a receptor for Herpes simplex virus 1/HHV-1. .; FUNCTION: (Microbial infection) Acts as a receptor for Herpes simplex virus 2/HHV-2. . |
Accessions | ENST00000629209.1 Q92956 ENST00000409119.5 F6UPZ7 ENST00000628337.2 ENST00000629542.2 A0A0D9SF52 ENST00000482602.5 F6Q0M4 ENST00000631202.2 ENST00000434817.5 ENST00000625695.2 ENST00000435221.6 ENST00000355716.5 [Q92956-1] ENST00000451778.5 ENST00000629075.2 B9A034 ENST00000426449.5 ENST00000621877.3 [Q92956-1] |